TENAYA THERAPEUTICS, INC.
Last · NASDAQ$0.391-0.13 (-24.95%)close · yahoo · 15h ago
Vol 18.08M ≈ 7.07M
MA10MA20MA50
Market cap$87.56M224.2M sh
P/E · TTM-1.0fwd -1.0 · eps -0.39 · loss
Beta2.88vs S&P 500
Div yield0.00%annual · TTM
52w range
$0.36$2.02
Volume18.1Msession
Issuer
Legal nameTENAYA THERAPEUTICS, INC.
HQUnited States (US)
ListingUS TNYA
ISINUS87990A1060
SectorHealthcare
IndustryDrugs (Biotechnology)
SIC2836
CurrencyUSD
Entity registrysec:0001858848
CIK0001858848
Websitewww.tenayatherapeutics.com
Employees70
AddressTenaya Therapeutics, Inc. 171 Oyster Point Boulevard 94080, South San Francisco
Loading chart…
OpenFilings analyst
Our analyst
10-K · 2026-03-11
From latest 10-K · 2026-03-11
- Operating Cf Burn
- Cash Runway Low
- Accumulated Deficit High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Cash Runway Low — Cash runway ~1.5 years
- Accumulated Deficit High — Accumulated deficit / equity 491%
Upcoming earnings
WED.11NOV
9:00 PM UTC+1
Period
Sep 2026
Est. EPS
−$0.10
Est. revenue
800,000
Press & signals
- GlobeNewswire
Tenaya Therapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)